The Impact of Iron Overload on the Immune System in Patients with β-Thalassemia and Treatment Recommendations --Review.
10.19746/j.cnki.issn.1009-2137.2025.05.046
- Author:
Yuan LIU
1
;
Tong-Hua YANG
1
Author Information
1. School of Medicine, Kunming University of Science and Technology, Kunming 650500, Yunnan Province, China.
- Publication Type:English Abstract
- Keywords:
β-thalassemia;
iron overload;
immune system;
iron chelators;
antioxidants
- MeSH:
Humans;
beta-Thalassemia/immunology*;
Iron Overload/therapy*;
Immune System;
Hematopoietic Stem Cell Transplantation
- From:
Journal of Experimental Hematology
2025;33(5):1546-1550
- CountryChina
- Language:Chinese
-
Abstract:
β-Thalassemia is an autosomal recessive genetic disorder caused by defects in the synthesis of the β-globin chains. Due to ineffective erythropoiesis and premature destruction of red blood cells, patients suffer from anemia, iron overload, organ damage, and impaired immune system. The impairment of the immune system is mainly due to the increase in the levels of reactive oxygen species (ROS) caused by iron overload, which induces DNA oxidation and leads to DNA damage. The treatment strategies for β-thalassemia mainly include gene therapy and allogeneic hematopoietic stem cell transplantation (allo-HSCT). However, iron overload in patients cannot be eliminated promptly after gene therapy and transplantation. Therefore, even if allo-HSCT is performed, the patient's hematopoietic function may still be impaired. Iron chelators and antioxidants have been proven to effectively intervene in the immune damage caused by iron overload. This article aims to review the research progress on the effects of iron overload on the immune system in patients with β-thalassemia, and provides relevant treatment recommendations for immune recovery.
